- Business Type:
- Manufacturer
- Year Established:
- 2009
- Total Revenue:
- US$50 Million - US$100 Million
- Main Markets:
- North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Company Description
Aprepitant170729-80-3,
Blonanserin 132810-10-7,
Methotrexate 59-05-2,
Disodium levofolinate 42476-21-1,
Calcium folinate pentahydrate 6035-45-6,
5-Methyltetrahydrofolate calcium (racemate) 26560-38-3,
L-5-Methyltetrahydrofolate calcium 151533-22-1,
Calcium levofolinate 80433-71-2, 2-Chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine 132813-14-0
Calcium folinate 1492-18-8,
Folinic acid 58-05-9,
Disodium folinate 163254-40-8,
5-Methyltetrahydrofolic acid (Racemate) 134-35-0,
Anhydro leucovorin, 5,10-methenyltetrahydrofolate 7444-29-3,
L-5-Methyltetrahydrofolic acid 31690-09-2
D-Cysteine HCL Monohydrate 207121-46-8,
D-Cysteine HCL Anhydrous 32443-99-5